Recently, ADVI Health’s director of strategic analytics, value and economics (SAVEs), Ashis Das, had an insight published to Health Economics, “What Clinical and HEOR Evidence Does CMS Expect for IRA Drug Price Negotiations?”

In the insight, Ashis details how HEOR leaders should prepare – and what type of evidence will withstand negotiation conversations – with the Centers for Medicare & Medicaid Services (CMS).

Read more in Health Economics.